Statement of total voting rights and shares forming the company’s share capital on March 10th, 2021

NEXT STORY
Acupath Laboratories Launches Guaranteed 24-Hour In-Lab Turnaround Time for COVID-19 PCR Test Results Without a Rush Fee
PREV STORY
Immuneering Expands Leadership Team with Appointment of Carolina Garcia Rizo, Ph.D., MBA, as Chief Business Officer
Subscribe to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Myriad Genetics and BeiGene Sign Agreement to Develop Companion Diagnostics for Use with BeiGene’s Novel PARP Inhibitor, BGB-290

SALT LAKE CITY, April 06, 2017 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a ...

author_avatar
NASDAQ Market News

Sensus Healthcare to Host Fourth Quarter 2019 Financial Results and Business Update Conference Call on February 13, 2020

author_avatar
NASDAQ Market News

Corbus Pharmaceuticals Presents Data Demonstrating ACR CRISS Score Reflects Patient-Reported Outcomes at 6th Systemic Sclerosis World E-Congress

author_avatar
NASDAQ Market News